Spectral AI Inc. Class A Common Stock Q2 2025 Earnings Recap

Spectral AI Inc. reported a net loss of $7.9 million for Q2 2025, driven by decreased research revenue and increased warrant liabilities, yet maintained a robust cash position to support future initiatives.

Key Takeaways

• Completed a $15 million debt financing agreement and raised $2.7 million in equity, ending the quarter with over $10 million in cash.
• Achieved a significant milestone with the FDA submission for the DeepView System in June 2025, anticipated to strengthen commercial efforts.
• Research and development revenue fell to $5.1 million, down from $7.5 million year-over-year, reflecting reduced reimbursements under the BARDA contract.
• General and administrative expenses decreased to $4.4 million, from $5.8 million, highlighting ongoing operational efficiencies.
• The net loss for the first half of 2025 improved to $5.1 million compared to $6.1 million in the same period last year, indicating deeper cost management efforts.